You have free access to this content

Hepatology

Cover image for Vol. 56 Issue 4

October 2012

Volume 56, Issue 4

Pages 1191–1590

  1. Introducing The AASLD President

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
    2. You have free access to this content
  3. Viral Hepatitis

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
      Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis (pages 1201–1213)

      Benjamin Krämer, Christian Körner, Moritz Kebschull, Andreas Glässner, Marianne Eisenhardt, Hans-Dieter Nischalke, Michael Alexander, Tilman Sauerbruch, Ulrich Spengler and Jacob Nattermann

      Article first published online: 31 AUG 2012 | DOI: 10.1002/hep.25804

    2. You have free access to this content
    3. You have free access to this content
      The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan (pages 1223–1230)

      Marcia Russell, Mary Patricia Pauly, Charles Denton Moore, Constance Chia, Jennifer Dorrell, Renee J. Cunanan, Gayle Witt and Scott Martin

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25755

    4. You have free access to this content
      25-hydroxyvitamin D3 suppresses hepatitis C virus production (pages 1231–1239)

      Takuya Matsumura, Takanobu Kato, Nao Sugiyama, Megumi Tasaka-Fujita, Asako Murayama, Takahiro Masaki, Takaji Wakita and Michio Imawari

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25763

    5. You have free access to this content
      Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein (pages 1240–1251)

      Leo L. Studach, Stephan Menne, Stefano Cairo, Marie Annick Buendia, Ronald L. Hullinger, Lydie Lefrançois, Philippe Merle and Ourania M. Andrisani

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25781

    6. You have free access to this content
      Comparison of hepatitis C virus treatment between incarcerated and community patients (pages 1252–1260)

      John P. Rice, David Burnett, Helena Tsotsis, Mary J. Lindstrom, Daniel D. Cornett, Patricia Voermans, Jill Sawyer, Rob Striker and Michael R. Lucey

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25770

    7. You have free access to this content
      Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus–coinfected patients (pages 1261–1270)

      Juan Macías, Juan Berenguer, Miguel A. Japón, José A. Girón-González, Antonio Rivero, Luis F. López-Cortés, Ana Moreno, Manuel Márquez, José A. Iribarren, Enrique Ortega, Pilar Miralles, Nicolás Merchante and Juan A. Pineda

      Article first published online: 11 SEP 2012 | DOI: 10.1002/hep.25791

    8. You have free access to this content
      Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases (pages 1271–1278)

      Hironori Ochi, Masashi Hirooka, Yohei Koizumi, Teruki Miyake, Yoshio Tokumoto, Yoshiko Soga, Fujimasa Tada, Masanori Abe, Yoichi Hiasa and Morikazu Onji

      Article first published online: 13 JUL 2012 | DOI: 10.1002/hep.25756

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
      Liver-specific ablation of Krüppel-associated box–associated protein 1 in mice leads to male-predominant hepatosteatosis and development of liver adenoma (pages 1279–1290)

      Karolina Bojkowska, Fabio Aloisio, Marco Cassano, Adamandia Kapopoulou, Francesca Santoni de Sio, Nadine Zangger, Sandra Offner, Cristina Cartoni, Charles Thomas, Simon Quenneville, Kai Johnsson and Didier Trono

      Article first published online: 27 AUG 2012 | DOI: 10.1002/hep.25767

    2. You have free access to this content
      Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism (pages 1291–1299)

      Claudia O. Zein, Rocio Lopez, Xiaoming Fu, John P. Kirwan, Lisa M. Yerian, Arthur J. McCullough, Stanley L. Hazen and Ariel E. Feldstein

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25778

    3. You have free access to this content
      Specific bile acids inhibit hepatic fatty acid uptake in mice (pages 1300–1310)

      Biao Nie, Hyo Min Park, Melissa Kazantzis, Min Lin, Amy Henkin, Stephanie Ng, Sujin Song, Yuli Chen, Heather Tran, Robin Lai, Chris Her, Jacquelyn J. Maher, Barry M. Forman and Andreas Stahl

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25797

    4. You have free access to this content
      Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study (pages 1311–1318)

      Lauren N. Bell, Jiangxia Wang, Sriya Muralidharan, Sadhana Chalasani, Allison M. Fullenkamp, Laura A. Wilson, Arun J. Sanyal, Kris V. Kowdley, Brent A. Neuschwander-Tetri, Elizabeth M. Brunt, Arthur J. McCullough, Nathan M. Bass, Anna Mae Diehl, Aynur Unalp-Arida, Naga Chalasani and for the Nonalcoholic Steatohepatitis Clinical Research Network

      Article first published online: 21 AUG 2012 | DOI: 10.1002/hep.25805

    5. You have free access to this content
      Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice (pages 1319–1330)

      Hiroyuki Tsuchiya, Yoshito Ikeda, Yu Ebata, Chihiro Kojima, Rikutaro Katsuma, Tatsuaki Tsuruyama, Tomohiko Sakabe, Kohei Shomori, Noriko Komeda, Shoko Oshiro, Hideharu Okamoto, Kazuko Takubo, Susumu Hama, Koichi Shudo, Kentaro Kogure and Goshi Shiota

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25798

  5. Hepatobiliary Malignancies

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Intraductal papillary neoplasm of the bile duct: A biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? (pages 1352–1360)

      Flavio G. Rocha, Hwajeong Lee, Nora Katabi, Ronald P. DeMatteo, Yuman Fong, Michael I. D'Angelica, Peter J. Allen, David S. Klimstra and William R. Jarnagin

      Article first published online: 27 AUG 2012 | DOI: 10.1002/hep.25786

    4. You have free access to this content
      Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing (pages 1361–1370)

      Diana Vetter, Michal Cohen-Naftaly, Augusto Villanueva, Youngmin A. Lee, Peri Kocabayoglu, Rebekka Hannivoort, Goutham Narla, Josep M. Llovet, Swan N. Thung and Scott L. Friedman

      Article first published online: 27 AUG 2012 | DOI: 10.1002/hep.25810

    5. You have free access to this content
      Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis (pages 1371–1379)

      Edoardo G. Giannini, Simona Marenco, Giacomo Borgonovo, Vincenzo Savarino, Fabio Farinati, Paolo Del Poggio, Gian Ludovico Rapaccini, Maria Anna Di Nolfo, Luisa Benvegnù, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani and for the Italian Liver Cancer (ITA.LI.CA) group

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25814

    6. You have free access to this content
      Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma (pages 1380–1390)

      Li Li, Ronghua Jin, Xiaoli Zhang, Fudong Lv, Lifeng Liu, Daojie Liu, Kai Liu, Ning Li and Dexi Chen

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25891

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
      Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions (pages 1391–1400)

      Andreas E. Kremer, Remco van Dijk, Pamela Leckie, Frank G. Schaap, Edith M.M. Kuiper, Thomas Mettang, Katrin S. Reiners, Ulrike Raap, Henk R. van Buuren, Karel J. van Erpecum, Nathan A. Davies, Christian Rust, Andreas Engert, Rajiv Jalan, Ronald P.J. Oude Elferink and Ulrich Beuers

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25748

    2. You have free access to this content
      Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis (pages 1401–1408)

      Harpreet K. Dhaliwal, Rory Anderson, Elizabeth L. Thornhill, Sarah Schneider, Elaine McFarlane, Dermot Gleeson and Lynne Lennard

      Article first published online: 7 SEP 2012 | DOI: 10.1002/hep.25760

    3. You have free access to this content
    4. You have free access to this content
      The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17a deleted dominant negative form of transforming growth factor beta receptor type ii mice (pages 1418–1426)

      Yugo Ando, Guo-Xiang Yang, Masanobu Tsuda, Kazuhito Kawata, Weici Zhang, Takahiko Nakajima, Koichi Tsuneyama, Patrick Leung, Zhe-Xiong Lian, Kazuichi Okazaki, William M. Ridgway, Gary L. Norman, Aftab A. Ansari, Xiao-Song He, Ross L. Coppel and M. Eric Gershwin

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25803

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
      Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents (pages 1427–1438)

      Yuko Kageyama, Hitoshi Ikeda, Naoko Watanabe, Masakazu Nagamine, Yoshika Kusumoto, Mitsuru Yashiro, Yumiko Satoh, Tatsuo Shimosawa, Koji Shinozaki, Tomoaki Tomiya, Yukiko Inoue, Takako Nishikawa, Natsuko Ohtomo, Yasushi Tanoue, Hiromitsu Yokota, Takatoshi Koyama, Kazuhiro Ishimaru, Yasuo Okamoto, Yoh Takuwa, Kazuhiko Koike and Yutaka Yatomi

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25780

    2. You have free access to this content
      Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis (pages 1439–1447)

      Monika Ferlitsch, Thomas Reiberger, Matthias Hoke, Petra Salzl, Bernadette Schwengerer, Gregor Ulbrich, Berit Anna Payer, Michael Trauner, Markus Peck-Radosavljevic and Arnulf Ferlitsch

      Article first published online: 27 AUG 2012 | DOI: 10.1002/hep.25806

    3. You have free access to this content
      LecT-hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients (pages 1448–1456)

      Kiyoaki Ito, Atsushi Kuno, Yuzuru Ikehara, Masaya Sugiyama, Hiroaki Saito, Yoshihiko Aoki, Teppei Matsui, Masatoshi Imamura, Masaaki Korenaga, Kazumoto Murata, Naohiko Masaki, Yasuhito Tanaka, Shuhei Hige, Namiki Izumi, Masayuki Kurosaki, Shuhei Nishiguchi, Michiie Sakamoto, Masayoshi Kage, Hisashi Narimatsu and Masashi Mizokami

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25815

  8. Liver Injury/Regeneration

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
      Structural analysis of oval-cell–mediated liver regeneration in rats (pages 1457–1467)

      Katalin Dezső, Veronika Papp, Edina Bugyik, Hargita Hegyesi, Géza Sáfrány, Csaba Bödör, Péter Nagy and Sándor Paku

      Article first published online: 30 JUL 2012 | DOI: 10.1002/hep.25713

    2. You have free access to this content
      Interleukin-33 Is hepatoprotective during liver ischemia/reperfusion in mice (pages 1468–1478)

      Nozomu Sakai, Heather L. Van Sweringen, R. Cutler Quillin, Rebecca Schuster, John Blanchard, Justin M. Burns, Amit D. Tevar, Michael J. Edwards and Alex B. Lentsch

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25768

    3. You have free access to this content
      Ectopic expression of murine CD47 minimizes macrophage rejection of human hepatocyte xenografts in immunodeficient mice (pages 1479–1488)

      Johan M. Waern, Qinggong Yuan, Urda Rüdrich, Pablo D. Becker, Kai Schulze, Helene Strick-Marchand, Nicholas D. Huntington, Behrend J. Zacher, Karsten Wursthorn, James P. DiSanto, Carlos A. Guzman, Michael P. Manns, Michael Ott and Michael Bock

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25816

    4. You have free access to this content
  9. Liver Biology/Pathobiology

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver (pages 1510–1520)

      Suman Verma, Phaedra Tachtatzis, Sue Penrhyn-Lowe, Cinzia Scarpini, Diana Jurk, Thomas Von Zglinicki, Nick Coleman and Graeme J. M. Alexander

      Article first published online: 27 AUG 2012 | DOI: 10.1002/hep.25787

    3. You have free access to this content
      Recruitment mechanisms of primary and malignant B cells to the human liver (pages 1521–1531)

      Shishir Shetty, Tony Bruns, Christopher J. Weston, Zania Stamataki, Ye H. Oo, Heather M. Long, Gary M. Reynolds, Guy Pratt, Paul Moss, Sirpa Jalkanen, Stefan G. Hubscher, Patricia F. Lalor and David H. Adams

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25790

    4. You have free access to this content
      Two immunogenic passenger dendritic cell subsets in the rat liver have distinct trafficking patterns and radiosensitivities (pages 1532–1545)

      Bin Yu, Hisashi Ueta, Yusuke Kitazawa, Toshiya Tanaka, Kensuke Adachi, Hiromitsu Kimura, Miwa Morita, Yasushi Sawanobori, Hai Xin Qian, Tatsuhiko Kodama and Kenjiro Matsuno

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25795

    5. You have free access to this content
      Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner (pages 1546–1556)

      Dahee Choi, Kyoung-Jin Oh, Hye-Sook Han, Young-Sil Yoon, Chang-Yun Jung, Seong-Tae Kim and Seung-Hoi Koo

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25809

    6. You have free access to this content
      Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver (pages 1557–1566)

      Xiao Qi Wang, Chung Mau Lo, Lin Chen, Cindy K.Y. Cheung, Zhen Fan Yang, Yong Xiong Chen, Michael N. Ng, Wan Ching Yu, Xiaoyan Ming, Wu Zhang, David W.Y. Ho, See Ching Chan and Sheung Tat Fan

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25820

  10. Reviews

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
  11. Hepatology Elsewhere

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
  12. Correspondence

    1. Top of page
    2. Introducing The AASLD President
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. Liver Biology/Pathobiology
    11. Reviews
    12. Hepatology Elsewhere
    13. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Cholangiocarcinoma: A cancer in search of the right classification (pages 1585–1586)

      Vincenzo Cardinale, Guido Carpino, Lola M. Reid, Eugenio Gaudio and Domenico Alvaro

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25705

    3. You have free access to this content
      Reply (page 1586)

      Mina Komuta and Tania Roskams

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25709

    4. You have free access to this content
      Antiviral or proviral action of mycophenolic acid in hepatitis B infection? (pages 1586–1587)

      Qiuwei Pan, Anneke J. van Vuuren, Luc J.W. van der Laan, Maikel P. Peppelenbosch and Harry L. A. Janssen

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25700

    5. You have free access to this content
    6. You have free access to this content
      Reply: (page 1588)

      Anna Mae Diehl

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25728

    7. You have free access to this content
      Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma (page 1589)

      Simonetta Pazzaglia, Loredana Cifaldi, Anna Saran, Valerio Nobili, Doriana Fruci and Anna Alisi

      Article first published online: 4 OCT 2012 | DOI: 10.1002/hep.25783

    8. You have free access to this content
      To feed or what to feed in cirrhosis? (page 1590)

      Richard D. Johnston, Grace E. Dolman and Guruprasad Aithal

      Article first published online: 6 JUL 2012 | DOI: 10.1002/hep.24771

SEARCH

SEARCH BY CITATION